An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer

Lignende værker

• A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
  af: McLaughlin, Ronan P., et al.
  Udgivet: (2019)
• Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
  af: He, Jichao, et al.
  Udgivet: (2019)
• Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression
  af: He, Jichao, et al.
  Udgivet: (2020)
• Co-regulated gene expression of splicing factors as drivers of cancer progression
  af: Koedoot, Esmee, et al.
  Udgivet: (2019)
• Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
  af: Liu, Ning Qing, et al.
  Udgivet: (2016)